1. LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
2. Pharmacyclics Inc, Sunnyvale, CA;
3. Research Institute and Hospital, National Cancer Center, Goyang, Korea;
4. Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;
5. Department of Haematological Medicine, King's College London, London, United Kingdom;
6. Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD;
7. Department of Pathology, Brigham and Women's Hospital, Boston, MA; and
8. Boston Veterans Administration Healthcare System, West Roxbury, MA